FDA regulatory considerations for oncology drug development.

Saved in:
Bibliographic Details
Title: FDA regulatory considerations for oncology drug development.
Authors: Moon, Hanlim1 hanlim.moon@medirama.co.kr, Zang, Dae Young2, Ryu, Min‐Hee3, Seo, YeonSook1, Oh, Bitna1, Hwang, Sunjin1, Farrand, Lee1,4
Source: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-4. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20521707
DOI:10.1002/prp2.1254